Analysed ROIVANT SCIENCES LTD (ROIV:NASDAQ) News Sources
Montes Archimedes Acquisition (ROIV) Upgraded to Buy: Here's What You Should Know
10-04-2026
yahoo.com
This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It.
03-04-2026
247wallst.com
Should Brepocitinib’s New Trials and Batoclimab’s Setback Require Action From Roivant Sciences (ROIV) Investors?
03-04-2026
yahoo.com
Immunovant Batoclimab Flops in Phase 3 TED as Roivant Expands Brepocitinib Into LPP
02-04-2026
marketbeat.com
Roivant Sciences Adds Brepocitinib LPP Trial as Batoclimab Misses Phase III TED Endpoint
02-04-2026
marketbeat.com
Priovant Expands Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP)
02-04-2026
yahoo.com
Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
02-04-2026
yahoo.com
New England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
28-03-2026
yahoo.com
Bernstein Initiates Coverage of Roivant Sciences Ltd. (ROIV) with an Outperform Rating
25-03-2026
yahoo.com
What is the current price of ROIVANT SCIENCES LTD (ROIV:NASDAQ)?
The current price of ROIVANT SCIENCES LTD (ROIV:NASDAQ) is $28.22.
ROIVANT SCIENCES LTD (ROIV:NASDAQ) absolute price change since previous trading day?
The absolute price change of ROIVANT SCIENCES LTD (ROIV:NASDAQ) since the previous trading day is $-0.26.
ROIVANT SCIENCES LTD (ROIV:NASDAQ) percentage price change since previous trading day?
The percentage price change of ROIVANT SCIENCES LTD (ROIV:NASDAQ) since the previous trading day is -0.9129%.
What is the most recent average sentiment score for ROIVANT SCIENCES LTD (ROIV:NASDAQ)?
The most recent average sentiment score for ROIVANT SCIENCES LTD (ROIV:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for ROIVANT SCIENCES LTD (ROIV:NASDAQ)?
The most recent sentiment for ROIVANT SCIENCES LTD (ROIV:NASDAQ) is .
SEC-8K** Filing Available For ROIVANT SCIENCES LTD (ROIV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.